These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30487515)

  • 1. Off-Label Medication in Children: Responsibilities of Pediatrician and Neonatologist.
    Das JC; Hossain MA; Shahidullah M; Mannan MA
    Mymensingh Med J; 2018 Oct; 27(4):912-916. PubMed ID: 30487515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlicensed and off-label uses of medicines: definitions and clarification of terminology.
    Aronson JK; Ferner RE
    Br J Clin Pharmacol; 2017 Dec; 83(12):2615-2625. PubMed ID: 28779556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
    Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
    Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maltese prescribers use of off-label and unlicensed medicines in children: perceptions and attitudes.
    Ellul I; Grech V; Attard-Montalto S
    Int J Clin Pharm; 2016 Aug; 38(4):788-92. PubMed ID: 27142871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
    Gavrilov V; Lifshitz M; Levy J; Gorodischer R
    Isr Med Assoc J; 2000 Aug; 2(8):595-7. PubMed ID: 10979352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I; Conroy S
    Drug Saf; 2002; 25(1):1-5. PubMed ID: 11820908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label prescribing in pediatric outpatients.
    Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
    Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlicensed and off-label uses of drugs in paediatrics: a review of the literature.
    Cuzzolin L; Zaccaron A; Fanos V
    Fundam Clin Pharmacol; 2003 Feb; 17(1):125-31. PubMed ID: 12588640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlicensed and off-label drug use: issues and recommendations.
    Conroy S
    Paediatr Drugs; 2002; 4(6):353-9. PubMed ID: 12038871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Off-label and Unlicensed Medicines in Children.
    Lee JH; Byon HJ; Choi S; Jang YE; Kim EH; Kim JT; Kim HS
    J Korean Med Sci; 2018 Sep; 33(37):e227. PubMed ID: 30190655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Off-label pediatric medicines in Spain].
    Piñeiro Pérez R; Núñez Cuadros E; Rodríguez Marrodán B; Escrig Fernández R; Gil Lemus MÁ; Manzano Blanco S; Calvo C
    An Pediatr (Engl Ed); 2021 Mar; 94(3):188.e1-188.e9. PubMed ID: 33509731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
    Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature.
    Mason J; Pirmohamed M; Nunn T
    Eur J Clin Pharmacol; 2012 Jan; 68(1):21-8. PubMed ID: 21779968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
    Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
    Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unlicensed and off-label drug use in children: implications for safety.
    Choonara I
    Expert Opin Drug Saf; 2004 Mar; 3(2):81-3. PubMed ID: 15006712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label medication use.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Sep; 50(9):11-3. PubMed ID: 22897212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
    Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
    Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions : Comparative regulation framework of off label prescriptions in pediatrics: a review.
    Guidi B; Parziale A; Nocco L; Maiese A; La Russa R; Di Paolo M; Turillazzi E
    Int J Clin Pharm; 2022 Feb; 44(1):264-269. PubMed ID: 34495453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
    Saiyed MM; Lalwani T; Rana D
    Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.